SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-23-000077
Filing Date
2023-05-15
Accepted
2023-05-15 16:26:59
Documents
13
Period of Report
2023-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20230515.htm   iXBRL 8-K 43797
  Complete submission text file 0001126234-23-000077.txt   213040

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20230515.xsd EX-101.SCH 2250
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20230515_def.xml EX-101.DEF 15000
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20230515_lab.xml EX-101.LAB 29064
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20230515_pre.xml EX-101.PRE 15559
7 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20230515_htm.xml XML 10968
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 23923008
SIC: 2834 Pharmaceutical Preparations